WASHINGTON • Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain. The Food and Drug Administration on Tuesday posted …
Read the original here:
FDA questions wider approval of Eli Lilly’s Cymbalta – Victorville Daily Press
